浙江银河国科消费健康股权投资基金

Zhejiang Yinhe Guoke Consumer Health Equity Investment Fund is a limited partnership equity investment fund in Zhejiang, China. According to public business registry listings, it was established on 2024-11-22 and is associated with Galaxy Innovation Capital (银河创新资本), with an LP type described as a VC/PE institution and a reported fund size in the RMB 100–300 million range. A news report also states the fund focuses on investing around Zhejiang’s “4+4” industrial clusters, including modern textiles & apparel and biopharma & medical devices, and it has been reported as the lead investor in a RMB 150 million Series B financing for Puyi Bio (普译生物).